{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:57:45Z","timestamp":1791593865387,"version":"4.3.4"},"reference-count":19,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"vor","delay-in-days":401,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jcin.2022.07.027","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T17:17:02Z","timestamp":1663607822000},"page":"1852-1860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents"],"prefix":"10.1016","volume":"15","author":[{"given":"David E.","family":"Kandzari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques J.","family":"Koolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gheorghe","family":"Doros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5100-0471","authenticated-orcid":false,"given":"Hector M.","family":"Garcia-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Roguin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie G.","family":"Gharib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald E.","family":"Cutlip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4063-9226","authenticated-orcid":false,"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2022.07.027_bib1","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/CIRCULATIONAHA.110.003210","article-title":"Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings","volume":"123","author":"Kolandaivelu","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2022.07.027_bib2","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(17)32249-3","article-title":"Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial","volume":"390","author":"Kandzari","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2022.07.027_bib3","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0140-6736(19)31877-X","article-title":"Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial","volume":"394","author":"Iglesias","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2022.07.027_bib4","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1161\/CIRCULATIONAHA.119.040241","article-title":"Randomized comparison of the polymer-free biolimus-coated Biofreedom stent with the ultrathin strut biodegradable polymer sirolimus-eluting Orsiro stent in an all-comers population treated with percutaneous coronary intervention: the SORT OUT IX trial","volume":"141","author":"Jensen","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2022.07.027_bib5","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1161\/CIRCULATIONAHA.120.052766","article-title":"Randomized clinical comparison of the dual-therapy CD34 antibody-covered sirolimus-eluting combo stent with the sirolimus-eluting Orsiro stent in patients treated with percutaneous coronary intervention: the SORT OUT X trial","volume":"143","author":"Jakobsen","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2022.07.027_bib6","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/CIRCULATIONAHA.118.034456","article-title":"Newer generation ultra-thin strut drug-eluting stents versus older second-generation thicker strut drug-eluting stents for coronary artery disease: a meta-analysis of randomized trials","volume":"138","author":"Bangalore","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2022.07.027_bib7","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1016\/j.jcin.2020.09.014","article-title":"Target lesion failure with current drug-eluting stents. Evidence from a comprehensive network meta-analysis","volume":"13","author":"Taglieri","year":"2020","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2022.07.027_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ahj.2017.08.001","volume":"193","author":"Doros","year":"2017","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2022.07.027_bib9","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1016\/j.jacc.2018.09.019","article-title":"Ultrathin bioresorbable polymer sirolimus-eluting stents versus thin durable polymer everolimus-eluting stents: BIOFLOW V 2-year results","volume":"72","author":"Kandzari","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2022.07.027_bib10","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jcin.2020.02.019","article-title":"Ultrathin bioresorbable-polymer sirolimus-eluting stents versus thin durable-polymer everolimus-eluting stents for coronary revascularization: 3-year outcomes from the randomized BIOFLOW V trial","volume":"13","author":"Kandzari","year":"2020","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2022.07.027_bib11","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0140-6736(18)31715-X","article-title":"Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularization: 5-year outcomes of the BIOSCIENCE randomised trial","volume":"392","author":"Pilgrim","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2022.07.027_bib12","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.jcin.2019.04.054","article-title":"Thin, very thin, or ultrathin strut biodegradable or durable polymer-coated drug-eluting stents: 3-year outcomes of BIO-RESORT","volume":"12","author":"Buiten","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2022.07.027_bib13","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/jamacardio.2019.1776","article-title":"Outcomes in patients treated with thin-strut, very thin-strut, or ultrathin-strut drug-eluting stents in small coronary vessels: a prespecified analysis of the randomized BIO-RESORT trial","volume":"4","author":"Buiten","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jcin.2022.07.027_bib14","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jcin.2020.12.011","article-title":"Biodegradable- versus durable-polymer drug-eluting stents for STEMI: final 2-year outcomes of the BIOSTEMI trial","volume":"14","author":"Pilgrim","year":"2021","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2022.07.027_bib15","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1093\/eurheartj\/ehab280","article-title":"Long-term follow-up after ultrathin vs. conventional 2nd-generation drug-eluting stents: a systematic review and meta-analysis of randomized controlled trials","volume":"42","author":"Madhavan","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2022.07.027_bib16","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2022.07.027_bib17","first-page":"351","article-title":"On the combination of independent two-sample tests of Wilcoxon","volume":"37","author":"van Elteren","year":"1960","journal-title":"Bull Int Stat Inst"},{"key":"10.1016\/j.jcin.2022.07.027_bib18","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jacc.2019.11.058","article-title":"Stent-related adverse events >1 year after percutaneous coronary intervention","volume":"75","author":"Madhavan","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2022.07.027_bib19","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.4244\/EIJ-D-21-00874","article-title":"Polymer-free biolimus-coated stents versus ultrathin-strut biodegradable polymer sirolimus-eluting stents: two-year outcomes of the randomized SORT OUT IX trial","volume":"18","author":"Ellert-Gregersen","year":"2022","journal-title":"EuroIntervention"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879822014649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879822014649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:16:44Z","timestamp":1761848204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879822014649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":19,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1936879822014649"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2022.07.027","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2022.07.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}